首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Total Synthesis of Tiacumicin B: Study of the Challenging β-Selective Glycosylations**
Authors:Dr Cédric Tresse  Dr Marc François-Heude  Vincent Servajean  Rubal Ravinder  Clémence Lesieur  Lucie Geiben  Dr Louis Jeanne-Julien  Vincent Steinmetz  Dr Pascal Retailleau  Dr Emmanuel Roulland  Prof Dr Jean-Marie Beau  Dr Stéphanie Norsikian
Institution:1. Institut de Chimie des Substances Naturelles, UPR 2301, CNRS Université Paris–Saclay, 91198 Gif-sur-Yvette, France;2. C-Tac, CitCom, UMR 8038, Faculté de Pharmacie, CNRS–Université de Paris, avenue de l'Observatoire 4, 75006 Paris, France
Abstract:We give a full account of the total synthesis of tiacumicin B (Tcn-B), a natural glycosylated macrolide with remarkable antibiotic properties. Our strategy is based on our experience with the synthesis of the tiacumicin B aglycone and on unique 1,2-cis-glycosylation steps. We used sulfoxide anomeric leaving-groups in combination with a remote 3-O-picoloyl group on the donors that allowed highly β-selective rhamnosylation and noviosylation that rely on H-bond-mediated aglycone delivery. The rhamnosylated C1–C3 fragment was anchored to the C4–C19 aglycone fragment by a Suzuki–Miyaura cross-coupling. Ring-size-selective Shiina macrolactonization provided a semiglycosylated aglycone that was engaged directly in the noviolysation step with a virtually total β-selectivity. Finally, a novel deprotection method was devised for the removal of a 2-naphthylmethyl ether on a phenol, and efficient removal of all the protecting groups provided synthetic tiacumicin B.
Keywords:antibiotics  cis-glycosylation  glycochemistry  natural products  total synthesis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号